alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › status

status

5 studies tagged status, dated 2004-12-01 to 2025-12-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review 2025-12-01
  2. Prediction of Mild Cognitive Impairment Status: Pilot Study of Machine Learning Models Based on Longitudinal Data From Fitness Trackers 2024-07-18
  3. Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status 2024-05-08

Studies

5 studies carry this tag.

Date range

2004 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • JMIR formative research 1
  • Journal of Alzheimer's disease : JAD 1
  • Neuroscience letters 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Validation status of cognitive digital assessments by the FDA BEST framework and context of use in preclinical AD studies: A systematic review

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-12-01 Cognitive tests and assessment

    Digital cognitive assessments have rapidly expanded in Alzheimer's disease (AD) research, offering a sensitive, scalable, and cost-effective alternative to traditional neuropsychological tests.

  2. Prediction of Mild Cognitive Impairment Status: Pilot Study of Machine Learning Models Based on Longitudinal Data From Fitness Trackers

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. JMIR formative research 2024-07-18 Cognitive tests and assessment

    Our results suggest that a longitudinal digital biomarker differentiates between controls and patients with MCI in a very cost-effective and noninvasive way and hence may be very useful for identifying patients with very early AD who can benefit from clinical trials and new, disease-modifying therapies.

  3. Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-05-08 Biomarkers

    In the community, the concentration of AD blood biomarkers varies in relation to medical conditions and systemic inflammation.

  4. ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroscience letters 2013-10-18 Genetics

    Genome-wide association studies (GWAS) have implicated a series of single nucleotide polymorphisms (SNPs) in Alzheimer's disease (AD) risk.

  5. Associations of cortical astrogliosis with cognitive performance and dementia status

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of Alzheimer's disease : JAD 2004-12-01 Biomarkers

    We examined 204 decedents of the autopsy component of the Honolulu-Asia Aging Study, a longitudinal cohort study, who had been clinically assessed for dementia.

All topic tags with their study counts